Toxoplasma gondii infection
Last updated: 31/10/2015
The Toxoplasma gondii infection in cats guidelines that the present article is updating were published in J Feline Med Surg 2013; 15: 631-637;44 this update has been compiled by Katrin Hartmann.
Toxoplasma gondii infection is common in cats, but the clinical picture is rare. Up to 50% of cats, especially free-roaming ones, have antibodies indicating infection and the presence of cystic stages. Clinical signs usually appear when cats become immunosuppressed – in these situations, cystic stages can be reactivated. Organs commonly affected are the CNS, muscle, lungs, and eyes. Cats can pose a risk for humans when they shed oocysts. However, this happens only once in their lifetime, usually only for three to ten days after ingestion of tissue cysts. Thus, cats that have antibodies to T. gondii do no longer shed oocysts and neither are nor will become a risk for humans.
Toxoplasma (T.) gondii is an obligate intracellular coccidian parasite that can infect virtually all species of warm-blooded animals, including people. Domestic cats and other felids are the natural hosts – non-feline species serve only as intermediates.1,2
Three infectious structures can be distinguished: sporozoites in oocysts, tachyzoites (the actively multiplying stage), and bradyzoites (the slowly multiplying stage) enclosed in tissue cysts. Oocysts are excreted in faeces, whereas tachyzoites and bradyzoites are found in tissues and milk.1,2
The entero-epithelial (coccidian) life cycle
This cycle is found only in the feline host. Most cats are infected by ingesting intermediate hosts – typically rodents – infected with tissue cysts. Bradyzoites are released in the stomach and intestine from the tissue cysts when digestive enzymes dissolve their wall. They enter epithelial cells of the small intestine and give rise to schizonts, initiate five types of predetermined asexual stages, and merozoites released from the schizonts eventually form male and female gamonts. After fertilization, a wall is formed around the fertilized macrogamont to form an oocyst (Figs. 2, 3). Oocysts are round to oval, 10 x 12 μm in size, and are still unsporulated (not infectious) when passed in faeces. After exposure to air and moisture for one to five days, they sporulate to contain two sporocysts, each with four sporozoites.1,2
The cycle is usually completed within three to ten days after ingestion of tissue cysts, which is the case in up to 97% of naive cats. Only after the rare event in which cats ingest oocysts or tachyzoites, formation of new oocyst is delayed and shedding can occur up to 18 days (rarely more). However, only 20% of cats fed oocysts will shed.1,2
The extra-intestinal life cycle
The extra-intestinal development of T. gondii is the same for all hosts, including cats, dogs, and people, whether tissue cysts or oocysts had been ingested. After the ingestion of oocysts, sporozoites hatch in the lumen of the small intestine and enter intestinal cells, including those in the lamina propria. Sporozoites divide into two by an asexual process known as endodyogeny, thereby becoming tachyzoites. These are lunate (falciform) in shape, approximately 6 x 2 μm, and multiply in almost any cell of the body. When the cell ruptures, releasing the tachyzoites, these infect new cells. Otherwise, tachyzoites multiply intracellularly for an undetermined period, and eventually encyst. Tissue cysts vary in size from 15 to 60 μm and usually conform to the shape of the parasitized cell. Tissue cysts are formed mainly in the CNS, muscles, and visceral organs, and probably persist for the life of the host. They can be reactivated after immunosuppression, which may then lead to clinical signs.1,2
Parasitaemia during pregnancy of the host can cause placentitis and spread of tachyzoites to the foetus. Many kittens born to queens infected with T. gondii during gestation become infected transplacentally or when suckling. Clinical signs are common in them, varying with the stage of gestation at the time of infection; some of these newborn kittens shed oocysts.1,2
Antibody prevalence to T. gondii varies geographically; in Portugal, 24% of the cats had antibodies3, in the USA 16% to 40% were seropositive, depending on the state2. However, only 3 of 326 faecal samples from cats in California and 1 out of 252 in Switzerland contained T. gondii oocysts.4 The annual burden in the environment is about 90 to 5,000 oocysts/square meter.5 The age of the cat does not play a role in the frequency of T. gondii shedding, but the season does: shedding is more common between July and December.6
The three major modes of transmission of T. gondii in all host species are congenital infection, ingestion of infected tissue, and ingestion of oocyst-contaminated food or water.2 Less important are blood transfusions and organ transplantations.1,2 Lactogenic transmission is suspected because the organism has been detected in queens milk.7
T. gondii blocks the innate aversion of rats for cat urine, instead makes them attracted by the feline pheromone, which may increase the likelihood of a cat capturing an infected rat. This reflects adaptive, ”behavioural manipulation“ by T. gondii in optimizing the chances for completing the parasite’s life cycle: it reproduces only in the feline intestine. The behavioural manipulation hypothesis postulates that a parasite will specifically manipulate host conduct essential for its transmission. However, the neural circuits for innate fear, anxiety, and acquired fright all overlap, raising the possibility that T. gondii may disrupt all of these non-specifically.8 Experimental infections have shown that T. gondii may change chemical messages in the CNS that affect rodent behaviour; the infection may lead to cyst formation in the CNS with production of tyrosine hydroxylase, resulting in a lack of dopamine.9-14
Meat contaminated with T. gondii cysts has been the primary source of infection in persons, and antibody prevalence in human beings is relatively high. Exposure from oocyst-contaminated soil or water is common. Indeed, water-borne outbreaks of toxoplasmosis have been reported worldwide and support the theory that exposure to environmental oocysts poses a significant health risk.15
Clinical toxoplasmosis develops during dissemination and intracellular replication of tachyzoites. It usually originates from reactivation of a latent infection rather than after a newly acquired infection. If a carrier cat is immunosuppressed, bradyzoites in tissue cysts replicate rapidly and disseminate again as tachyzoites. Clinical toxoplasmosis has been documented in cats infected with feline immunodeficiency virus (FIV) or feline leukaemia virus (FeLV).16 Commonly used doses of glucocorticoids do predispose to reactivation.17 However, administration of cyclosporine to cats with renal transplants or dermatologic disease has been associated with clinically manifestations.18-20
The most commonly affected tissues are the CNS, muscles (Fig. 4), lungs (Fig. 5) and eyes. Hepatic and pancreatic involvement is less likely. Cats with toxoplasmosis show neurologic signs (e.g., seizures, ataxia), muscle hyperesthesia, dyspnoea, uveitis, icterus, diarrhoea, fever, depression, anorexia, and weight loss.2 Transplacentally or lactogenically infected kittens develop more severe signs and frequently die of pulmonary or hepatic disease.21 Immune complex formation22 and deposition in tissues as well as delayed hypersensitivity reactions may be involved in chronic forms of toxoplasmosis. Since T. gondii is not cleared from the body, neither naturally nor through treatment, toxoplasmosis may recur.
Immunity to T. gondii in the cat is poorly understood. In the mouse and in humans, it is highly dependent on cell-mediated effector responses.23
All infected cats develop IgG and IgA antibodies, about 80% also have IgM antibodies. IgG can take four to six weeks to appear, and maximal antibody titres are achieved within two to three weeks after first appearance.2
Clinical toxoplasmosis is ideally diagnosed by detection of the organism in muscle biopsies or bronchoalveolar lavage, or by PCR in CSF or humor aqueous. During acute illness, tachyzoites can be detected in tissues and body fluids by cytology. They are rarely found in blood, but occasionally in CSF, fine-needle aspirates of organs (e.g., lymph nodes), and transtracheal or bronchoalveolar washings, and are common in the peritoneal and thoracic fluids of animals developing thoracic effusions or ascites. Detection of tachyzoites confirms the diagnosis.
A tentative diagnosis may be based on increasing IgM titers, exclusion of other causes of the clinical signs, and a beneficial clinical response to an anti-toxoplasma drug.1,2
Oocyst shedding is diagnosed by microscopy of faecal samples. Diagnosis of the disease is only confirmed when the organism is found in body fluids or tissue. If suitable samples cannot be taken, a tentative diagnosis is sometimes based on rising IgM titers, exclusion of other causes for the clinical signs, and a favourable clinical response to anti-T. gondii drugs.1,2
Detection of oocysts in faeces
T. gondii oocysts are 10 μm in size and best demonstrated by centrifugation using Sheather’s sugar solution (saccharose solution with a specific gravity of 1.27 g/ml) during the shedding period (Fig. 6). T. gondii oocysts are morphologically indistinguishable from those of Hammondia hammondi, Besnoitia orcytofelisi, and Besnoitia darling.2 A CsCl method for easy purification of T. gondii oocysts from faeces of infected cats has been described.15
Detection of tachyzoites
Ante-mortem diagnosis of clinical toxoplasmosis ideally is based on the detection of the organism by cytology or PCR. Tachyzoites may be detected in various tissues and body fluids during acute illness (Fig. 7). They are rarely found in blood, but occasionally in CSF or aqueous humour, fine-needle aspirates of organs (e. g. lymph nodes), and transtracheal or bronchoalveolar washings. Detection of tachyzoites results in a definitive diagnosis. Alternatively, a PCR can be performed using CSF, aqueous humour, or bronchoalveolar lavage fluid.
Using the immunofluorescence test (IFA), antibodies of the IgM, IgG, and IgA isotypes can be detected. For assessing human health risks, test results from healthy cats are useful. A seronegative cat may be shedding oocysts (early during infection, before antibodies had time to develop) and will likely shed oocysts if exposed for the first time. An antibody-positive cat is unlikely to shed oocysts: antibodies need two to three weeks to develop, by that time cats usually do no longer shed, and it sheds only once in its lifetime. It is also unlikely to shed oocysts if re-exposed or immunosuppressed.1
Antibodies are commonly found in both healthy and sick cats. Thus, their presence does not prove clinical toxoplasmosis. Antibodies of the IgM class are commonly detected in healthy cats and do not correlate with clinical signs.
Antibody test results from healthy cats are useful to assess the health risk for humans. An antibody-negative cat could be shedding oocysts (early after infection, before antibodies have developed) or will shed oocysts if exposed; this cat poses the greatest public health risk.
An antibody-positive cat is unlikely to shed oocysts, because antibodies need two to three weeks to develop, and by that time, the infection has been controlled; also, shedding usually occurs only once in its lifetime. A seropositive cat is also unlikely to shed oocysts when re-exposed or immunosuppressed.1 In one study, cats inoculated with T gondii tissue cysts were orally re-challenged several years later, and a few of them did shed oocysts after this second challenge – although only low amounts and over a short time.38 This, however, has never been shown to occur in naturally infected cats. Thus, the risk of shedding by an antibody-positive cat is low.
Antibodies are common in both healthy and diseased cats and therefore do not prove clinical toxoplasmosis. Not only IgG antibodies, but also antibodies of the IgM class are commonly detected in healthy cats and stay high over long periods; thus their detection is of no use either for diagnosing toxoplasmosis. T gondii-specific IgM is detected in the serum of cats with latent or reactivated infection and titers therefore do not indicate recent exposure. If increasing IgM titers are detected, however, this may raise the suspicion of clinical toxoplasmosis.
|Drug||ABCD recommendation||Comment||Evidence-based grade|
|10-12 mg/kg PO q12h||III|
Prednisolone acetate (1%)
|Use in addition to systemic antibiotic treatment|
Apply topically to the eye q6-8h
|For cats with toxoplasma-induced uveitis (to avoid secondary glaucoma and lens luxation)||IV|
Table 1. Treatment of Toxoplasmosis
Clindamycin is the treatment of choice24 and should be administered at 10 – 12 mg/kg orally q 12 h for four weeks (Table 1). Cats with systemic disease and uveitis should be treated with clindamycin in combination with topical, oral, or parenteral glucocorticoids, to avoid secondary glaucoma and lens luxation.25 Prednisolone acetate (1% solution) applied topically to the eye three to four times daily is generally sufficient.
Clinical signs not involving the eyes or the CNS usually begin to resolve within the first two to three days of clindamycin administration. CNS and ocular toxoplasmosis tend to respond more slowly. In cases of pulmonary toxoplasmosis, radiographic abnormalities might not resolve for several weeks. Prognosis is usually poor in pulmonary or hepatic disease, particularly in immunocompromised animals.26
Prevention of infection
Preventing toxoplasmosis in cats involves measures intended to reduce the incidence of infections and the shedding of oocysts into the environment. Cats should preferably be fed commercially available, processed food. Prevalence of feline T. gondii infection is higher in countries where raw meat is fed. Freezing or irradiation can kill tissue cysts without affecting meat quality. Pets should be prevented from hunting and eating intermediate hosts (rodents) or mechanical vectors, such as cockroaches and earthworms. If meat is fed, it should be thoroughly cooked, even if frozen. Cats should be prevented from entering buildings where food-producing animals are housed or where feed storage areas are located.1
Public health considerations
Public heath issues have come into focus, partially because of the increasing number of immunocompromised persons (e.g. after infection with human immunodeficiency virus). Also, recent research linking psychological and cognitive disorders (e.g. reduced IQ, as evidenced by psychomotor and verbal intelligence tests) to T. gondii infection may have contributed (Box 1). A recent survey amongst obstetrician-gynaecologists in the USA to determine their knowledge and practices about toxoplasmosis prevention and testing found that most overestimated the risk of cat ownership vs environmental risk factors.27 A systematic review of risk factors for pregnant women is available;28 it reports a relatively low risk of cat ownership.
Veterinarians commonly get questions from clients whether or not to get rid of their cat. If hygiene recommendations are followed (Box 2, 3), the risk of transmission is low (Box 4)
- 1 Dubey JP. Toxoplasma update. Proceedings of the WSAVA Congress; 2005.
- 2 Dubey JP, Lappin MR. Toxoplasmosis and Neosporosis. In: Greene CE (ed). In Infectious Disease of the Dog and Cat. Philadelphia: Saunders, W.B., 2006, pp 754-775.
- 3 Duarte A, Castro I, Pereira da Fonseca IM, Almeida V, Madeira de Carvalho LM, Meireles J, et al. Survey of infectious and parasitic diseases in stray cats at the Lisbon Metropolitan Area, Portugal. J Feline Med Surg 2010; 12: 441-446.
- 4 Berger-Schoch AE, Herrmann DC, Schares G, Muller N, Bernet D, Gottstein B, et al. Prevalence and genotypes of Toxoplasma gondii in feline faeces (oocysts) and meat from sheep, cattle and pigs in Switzerland. Vet Parasitol 2011; 177: 290-297.
- 5 Dabritz HA, Miller MA, Atwill ER, Gardner IA, Leutenegger CM, Melli AC, et al. Detection of Toxoplasma gondii-like oocysts in cat feces and estimates of the environmental oocyst burden. J Am Vet Med Assoc 2007; 231: 1676-1684.
- 6 Herrmann DC, Pantchev N, Vrhovec MG, Barutzki D, Wilking H, Frohlich A, et al. Atypical Toxoplasma gondii genotypes identified in oocysts shed by cats in Germany. Int J Parasitol 2010; 40: 285-292.
- 7 Powell CC, Brewer M, Lappin MR. Detection of Toxoplasma gondii in the milk of experimentally infected lactating cats. Vet Parasitol 2001; 102: 29-33.
- 8 Vyas A, Kim SK, Giacomini N, Boothroyd JC, Sapolsky RM. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc Natl Acad Sci U S A 2007; 104: 6442-6447.
- 9 Flegr J, Havlicek J. Changes in the personality profile of young women with latent toxoplasmosis. Folia Parasitol 1999; 46: 22-28.
- 10 Hrda S, Votypka J, Kodym P, Flegr J. Transient nature of Toxoplasma gondii-induced behavioral changes in mice. J Parasitol 2000; 86: 657-663.
- 11 Havlicek J, Gasova ZG, Smith AP, Zvara K, Flegr J. Decrease of psychomotor performance in subjects with latent ‘asymptomatic’ toxoplasmosis. Parasitology 2001; 122: 515-520.
- 12 Webster JP. Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. Microbes Infect 2001; 3: 1037-1045.
- 13 Flegr J, Havlicek J, Kodym P, Maly M, Smahel Z. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect Dis 2002; 2: 11.
- 14 Flegr J, Preiss M, Klose J, Havlicek J, Vitakova M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol 2003; 63: 253-268.
- 15 Staggs SE, See MJ, Dubey JP, Villegas EN. Obtaining highly purified Toxoplasma gondii oocysts by a discontinuous cesium chloride gradient. J Vis Exp 2009.
- 16 Davidson MG, Rottman JB, English RV, Lappin MR, Tompkins MB. Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am J Pathol 1993; 143: 1486-1497.
- 17 Lappin MR, Dawe DL, Windl PA, Greene CE, Prestwood AK. The effect of glucocorticoid administration on oocyst shedding, serology, and cell mediated immune responses of cats with recent or chronic toxoplasmosis. J Am Anim Hosp Assoc 1992; 27: 625-632.
- 18 Beatty J, Barrs V. Acute toxoplasmosis in two cats on cyclosporin therapy. Aust Vet J 2003; 81: 339.
- 19 Last RD, Suzuki Y, Manning T, Lindsay D, Galipeau L, Whitbread TJ. A case of fatal systemic toxoplasmosis in a cat being treated with cyclosporin A for feline atopy. Vet Dermatol 2004; 15: 194-198.
- 20 Barrs VR, Martin P, Beatty JA. Antemortem diagnosis and treatment of toxoplasmosis in two cats on cyclosporin therapy. Aust Vet J 2006; 84: 30-35.
- 21 Dubey JP, Lappin MR, Thulliez P. Diagnosis of induced toxoplasmosis in neonatal cats. J Am Vet Med Assoc 1995; 207: 179-185.
- 22 Lappin MR, Cayatte S, Powell CC, Gigliotti A, Cooper C, Roberts SM. Detection of Toxoplasma gondii antigen-containing immune complexes in the serum of cats. Am J Vet Res 1993; 54: 415-419.
- 23 Sanchez Y, Rosado Jde D, Vega L, Elizondo G, Estrada-Muniz E, Saavedra R, et al. The unexpected role for the aryl hydrocarbon receptor on susceptibility to experimental toxoplasmosis. J Biomed Biotechnol 2010; 2010: 505694.
- 24 Davidson MG. Toxoplasmosis. Vet Clin North Am Small Anim Pract 2000; 30: 1051-1062.
- 25 Lappin MR, Greene CE, Winston S, Toll SL, Epstein ME. Clinical feline toxoplasmosis. Serologic diagnosis and therapeutic management fo 15 cases. J Vet Intern Med 1998; 3: 139-143.
- 26 Dubey JP, Lindsay DS, Lappin MR. Toxoplasmosis and other intestinal coccidial infections in cats and dogs. Vet Clin North Am Small Anim Pract 2009; 39: 1009-1034, v.
- 27 Jones JL, Krueger A, Schulkin J, Schantz PM. Toxoplasmosis prevention and testing in pregnancy, survey of obstetrician-gynaecologists. Zoonoses Public Health 2010; 57: 27-33.
- 28 Leroy V, 3) HftEGp. Systematic review of risk factors for Toxoplasma gondii infection in pregnang women. (unpublished material) Bordeaux, France 2005.
- 29 Lunden A, Uggla A. Infectivity of Toxoplasma gondii in mutton following curing, smoking, freezing or microwave cooking. Int J Food Microbiol 1992; 15: 357-363.
- 30 Dubey JP. Long-term persistence of Toxoplasma gondii in tissues of pigs inoculated with T gondii oocysts and effect of freezing on viability of tissue cysts in pork. Am J Vet Res 1988; 49: 910-913.
- 31 Dubey JP. Toxoplasma gondii oocyst survival under defined temperatures. J Parasitol 1998; 84: 862-865.
- 32 Dubey JP, Kotula AW, Sharar A, Andrews CD, Lindsay DS. Effect of high temperature on infectivity of Toxoplasma gondii tissue cysts in pork. J Parasitol 1990; 76: 201-204.
- 33 Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol 2010; 26: 190-196.
- 34 Hill SL, Cheney JM, Taton-Allen GF, Reif JS, Bruns C, Lappin MR. Prevalence of enteric zoonotic organisms in cats. J Am Vet Med Assoc 2000; 216: 687-692.
- 35 Behymer RD, Harlow DR, Behymer DE, Franti CE. Serologic diagnosis of toxoplasmosis and prevalence of Toxoplasma gondii antibodies in selected feline, canine, and human populations. J Am Vet Med Assoc 1973; 162: 959-963.
- 36 Sengbusch HG, Sengbusch LA. Toxoplasma antibody prevalence in veterinary personnel and a selected population not exposed to cats. Am J Epidemiol 1976; 103: 595-597.
- 37 DiGiacomo RF, Harris NV, Huber NL, Cooney MK. Animal exposures and antibodies to Toxoplasma gondii in a university population. Am J Epidemiol 1990; 131: 729-733.
- 38 Flegr J, Hrda S, Tachezy J. The role of psychological factors in questionnaire-based studies on routes of human toxoplasmosis transmission. Cent Eur J Public Health 1998; 6: 45-50.
- 39 Dubey JP. Duration of immunity to shedding of Toxoplasma gondii oocysts by cats. J Parasitol 1995; 81: 410-415.
- 40 Lindsay DS, Dubey JP, Butler JM, Blagburn BL. Mechanical transmission of Toxoplasma gondii oocysts by dogs. Vet Parasitol 1997; 73: 27-33.
- 41 Wallace MR, Rossetti RJ, Olson PE. Cats and toxoplasmosis risk in HIV-infected adults. Jama 1993; 269: 76-77.
- 42 Lappin MR. Cat ownership by immunosuppressed people. In: August JR (ed). In: Consultations in Feline Medicine. 4th ed. Philadelphia: Saunders, W. B., 2001, pp 18-27.
- 43 Lappin MR, George JW, Pedersen NC, Barlough JE, Murphy CJ, Morse LS. Primary and secondary Toxoplasma gondii infection in normal and feline immunodeficiency virus-infected cats. J Parasitol 1996; 82: 733-742.
- 44 Hartmann K, Addie D, Bélak S, Boucraut-Baralon C, Egberink H, Frymus T, et al. Toxoplasma gondii infection in cats. ABCD guidelines on prevention and management. J Feline Med Surg 2013; 15: 631-637.